Great chart and critical point on what plasma can treat.I am...

Great chart and critical point on what plasma can treat.
I am bullish too on the long run for CSL.
I am making the point from market point of view and investor returns over next 1 to 5 years, not long term like 10+ years.
From market point of view, right now if IVIG market for CIDP is in doubt due to VYVGART, there has to be a replacement around the corner. That is where CSL 112 comes in over next 12 months.
As the chart shows there are many areas plasma potentially can find solutions. But for investors to put money in and give high PE they need certainty of returns over next 5 years to give high PE ratios like what they have done before. As soon as csl112 or any other product from the pipeline with substantial market presence becomes visible, I am sure investors will price it at higher PE. Even now CSL has around 25 pe on future earnings for next 3 years , which is pretty good considering high interest rate available.
I think this is the market reality not withstanding all the potential good things CSL is capable off in the future.